ATP Assays Market

ATP Assays Market Size by Product (Consumables (Reagents, Microplate), Instruments (Luminometer, Spectrophotometer)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, F&B, Academics) & Region - Global Forecast to 2028

Report Code: AST 7417 Jun, 2023, by marketsandmarkets.com

The global size of ATP assays market in terms of revenue was estimated to be worth USD 0.3 billion in 2023 and is poised to reach USD 0.5 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The expansion of this market is primarily propelled by the shift from culture-based tests to rapid tests, rising demand for cell-based assays in research, and the rising demand for ATP assays in pharmaceutical companies. However, lack of ability to differentiate between extracellular and intracellular ATP are factors restraining the growth of this market.

Global ATP Assays Market Trends

ATP Assays Market

To know about the assumptions considered for the study, Request for Free Sample Report

ATP Assays Market

ATP Assays Market Dynamics

Driver: Increasing food safety concerns

Technological advancements have supported the food supply to be more distinct than ever before. To ensure best-quality products with lowest health risks, several governments and companies have declared regulations to stipulate tolerable levels of contaminants, residues, and additives in food products. Under the Food Safety Modernization Act (FSMA), food processing facilities should have food safety programs in place and collect quantitative data to determine that their cleaning and sanitation programs are working. It lowers the risk of foodborne illnesses, closures, and recalls and can also increase efficiency and decrease costs. According to the WHO, in 2022, unsafe food containing harmful bacteria, viruses, parasites, or chemical substances, resulted in more than 200 diseases, ranging from diarrhea to cancers. An estimated 600 million (almost 1 in 10 people in the world) fall ill after eating contaminated food, and 420,000 die every year, resulting in the loss of 33 million healthy life years (DALYs).

Restraint: High cost of instruments

Cell biology implies extensive research on the development of new therapies, such as stem cell and gene therapies. The instruments, reagents, and other products associated with these research activities are made to be of high quality to obtain accurate results. In biopharmaceutical companies, the overall cost of production of biopharmaceuticals increases significantly due to the use of expensive systems. The cost of research in cell biology is high because of the need to maintain high-quality standards (use of high-grade, expensive products) and comply with guidelines set up by regulatory authorities. Furthermore, it becomes difficult for small hospitals, diagnostic laboratories, and research & academic laboratories to acquire these instruments owing to budget constraints. In addition, the maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. This is a major factor limiting the adoption of instruments utilized for ATP assays in both clinical and research applications, especially in emerging markets.

Opportunity: Technological enhancements in ATP assay probes

ATP is a universal mediator of metabolism and signaling across unicellular and multicellular species. There is a basic interdependence between the dynamics of ATP and the physiology that arises at the intracellular and extracellular levels. Thus, characterizing and recognizing ATP dynamics offers valuable mechanistic insights into processes that varies from neurotransmission to the chemotaxis of immune cells. Therefore, there is a requirement for a methodology to interrogate both the temporal and spatial components of ATP dynamics from the subcellular to organismal levels in live specimens. In the last several decades, a number of molecular probes that are detailed to ATP have been developed. These probes have been combined with imaging approaches, mostly optical microscopy, to allow the qualitative and quantitative detection of this critical molecule.

Challenge: Survival of small players and new entrants

The survival of small players and new emrging players in the ATP assays market is a substantial challenge. Established players such as Thermo Fisher Scientific. (US), Merck KGaA (Germany), Lonza (Switzerland), PerkinElmer (US), and NEOGEN Corporation (US) hold for a major share of the market. These players have a robust product portfolio and deep brand recognition. As a result, it is difficult for small players and new entrants to participate with established players. Also, as large investments are wanted for the R&D and launch of innovative products in the market, it is hard for small players to sustain their operations and compete with established players that have huge R&D budgets.

ATP Assays Market Ecosystem Map

ATP Assays Market Ecosystem

By product, the instruments segment is accounted for the second largest share of the ATP assays industry during the forecast period

Based on products, within the ATP assays market, there are consumables & accessories as well as instruments, with consumables & accessories holding a significant portion. This predominance is attributed to the widespread utilization of ATP assays in research institutes to assess cell viability, the growing demand for tumor testing and cell proliferation (especially in cancer) driven by the increase in chronic diseases, and the frequent procurement of consumables by pharmaceutical and biotechnology companies.

The contamination testing accounted for the largest share of the ATP assays industry during the forecast period.

Based on applications, The ATP assays market is divided into segments including contamination testing, disease testing, and drug delivery & development. The significant share of the contamination testing segment can be attributed to various factors. These factors include the escalating regulatory requirements imposed on pharmaceutical and food & beverage companies to ensure uncontaminated production, and the surge in drug discovery activities driven by the COVID-19 pandemic

The pharmaceutical & biotechnology companies segment accounted for the largest share of the ATP assays industry in 2022, by end user

Based on end users, The ATP assays market is categorized into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The dominance of this segment can be attributed to several significant factors. These factors include the substantial presence of pharmaceutical players who are making noteworthy investments in this market, the increasing regulatory approvals for cell culture-based vaccines that necessitate the use of ATP assays in contamination testing, the expansion of commercial activities by various pharmaceutical companies, the growing demand for cell and gene therapies to address chronic diseases, extensive research and development endeavors in the pharmaceutical & biopharmaceutical sector, the heightened production of drugs for COVID-19, the rising adoption of cell-based assays for drug development, and the user-friendly nature of ATP assays in contamination testing.

North America to witness significant growth in ATP assays industry from 2023 to 2028

On the basis of region, the ATP Assays market is divided into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2023, North America projected to lead market share of the market. This can be attributed to the use of advanced technologies in microbial detection, rising demand for cell-based assays in research, and the presence of high-quality infrastructure for clinical and laboratory research are also supporting market growth

ATP Assays Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in this market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), Neogen Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest,Inc. (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology,Inc. (US).

Scope of the ATP Assays Industry

Report Metric 

Details 

Market Revenue in 2023

$0.3 billion

Projected Revenue by 2028

$0.5 billion

Revenue Rate

Poised to Grow at a CAGR of 7.8%

Market Driver

Increasing food safety concerns

Market Opportunity

Technological enhancements in ATP assay probes

The study categories the ATP Assays Market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Consumables & Accessories
  • Reagent
  • Microplates
  • Other Consumables & Accessories
  • Instruments
  • Luminometers
  • Spectrophotometers

By Application

  • Contamination Testing
  • Disease Testing
  • Drug Dsicovery and Development

By End User

  • Pharmaceutical & Biotechnology companies
  • Food and Beverage Industry
  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutions

By Region

  • North America
    • US
    • Canada
  • Europe
    • France
    • Spain
    • UK
    • Italy
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa

Recent Developments of ATP Assays Industry

  • In January 2022, Agilent Technologies launched Seahorse XF Pro Analyzer, enabling operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fate, fitness, and function.
  • In May 2021, Neogen Corporation launched AccuPoint Advanced NG. It remains the only sanitation monitoring system in the market to utilize a flat tip sampler for maximized recovery of ATP and feature RFID technology for streamlined testing processes.
  • In October 2021, Abcam has doubled the footprint of its immunoassay kit R&D and manufacturing facility in Eugene, Oregon. This enhanced capacity is another component of Abcam’s growth journey in the US and will further enable its commitment to support the research and biopharma sector globally.
  • In May 2020, Thermo Fisher launched the Orbitrap 240 Mass Spectrometer. It is designed to give proteomics, metabolomics, and biopharmaceutical characterization to small molecules, which aid in research and high-throughput analyses. The new system helps drive discovery and identification with increased accuracy for confident scale-up along with operational simplicity and speed.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 29)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION AND SCOPE 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKET SEGMENTATION
                    FIGURE 1 ATP ASSAYS MARKET SEGMENTATION
                    FIGURE 2 ATP ASSAYS INDUSTRY: REGIONAL SEGMENTATION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED 
          TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
                                FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
          FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC INC.
          FIGURE 10 GLOBAL MARKET: BY PRODUCT
          FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          FIGURE 12 CAGR PROJECTIONS: MARKET
          FIGURE 13 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 14 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: MARKET
    2.8 RECESSION IMPACT ON MARKET 
          TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
          TABLE 4 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 5 US HEALTHCARE EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 15 ATP ASSAYS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 ATP ASSAYS INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 ATP ASSAYS MARKET OVERVIEW 
          FIGURE 19 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET
    4.2 ASIA PACIFIC: ATP ASSAYS INDUSTRY, BY END USER AND COUNTRY (2022) 
          FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
    4.3 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE IN MARKET DURING FORECAST PERIOD
    4.4 MARKET, BY REGION (2023–2028) 
          FIGURE 22 NORTH AMERICA TO DOMINATE GLOBAL MARKET IN 2028
    4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
 
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 24 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 6 ATP ASSAYS INDUSTRY: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing food safety concerns globally
                    5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies
                    5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D
                                FIGURE 25 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
                    5.2.1.4 Increasing prevalence of cancer globally
                                TABLE 7 ESTIMATED NEW CANCER CASES IN US, 2023
                                FIGURE 26 GLOBAL CANCER INCIDENCE AND MORTALITY, 2020
                    5.2.1.5 Shift from culture-based tests to rapid tests
                    5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of instruments and reagents
                    5.2.2.2 Inability to differentiate between extracellular and intracellular ATP
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Technological enhancements in ATP assay probes
                    5.2.3.2 Growth prospects in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Low survival rate for small players and new entrants
    5.3 INDUSTRY TRENDS 
           5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES
           5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2
    5.4 TECHNOLOGY ANALYSIS 
           5.4.1 HOMOGENEOUS TIME-RESOLVED FLUORESCENCE TECHNOLOGY FOR RAPID SCREENING OF ATP CONCENTRATIONS
           5.4.2 EASE OF USE OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYZERS IN CLINICAL LABORATORIES
           5.4.3 ADVANCED ASSAY STABILITY (AAS) SYSTEMS TO MATCH ROOM TEMPERATURE WHILE PERFORMING ASSAYS
           5.4.4 OTHER TECHNOLOGICAL INNOVATIONS
    5.5 REGULATORY ANALYSIS 
           5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.5.1.1 North America
                               5.5.1.1.1 US
                               5.5.1.1.2 Canada
                    5.5.1.2 Europe
                    5.5.1.3 Asia Pacific
                    5.5.1.4 Rest of the World
    5.6 PATENT ANALYSIS 
           5.6.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS
                    FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)
           5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–JUNE 2023)
           5.6.3 LIST OF PATENTS/PATENT APPLICATIONS IN MARKET
    5.7 VALUE CHAIN ANALYSIS 
          FIGURE 29 MARKET: VALUE CHAIN ANALYSIS
    5.8 ECOSYSTEM MARKET MAP 
          FIGURE 30 MARKET: ECOSYSTEM MARKET MAP
    5.9 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 8 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF SUPPLIERS
           5.9.4 BARGAINING POWER OF BUYERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 PRICING ANALYSIS 
           5.10.1 AVERAGE SELLING PRICE, BY KEY PLAYER
                     TABLE 9 AVERAGE SELLING PRICE, BY KEY PLAYER
                     TABLE 10 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD)
           5.10.2 AVERAGE SELLING PRICE TREND
    5.11 KEY CONFERENCES AND EVENTS IN 2023–2024 
           TABLE 11 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ATP ASSAY PRODUCTS
           5.12.2 BUYING CRITERIA FOR ATP ASSAYS
                     FIGURE 32 KEY BUYING CRITERIA FOR END USERS
 
6 ATP ASSAYS MARKET, BY APPLICATION (Page No. - 83)
    6.1 INTRODUCTION 
          TABLE 12 ATP ASSAYS INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
    6.2 CONTAMINATION TESTING 
           6.2.1 INCREASING REQUIREMENTS TO MEET REGULATORY MANDATES FOR QUALITY TESTING TO DRIVE MARKET
                    TABLE 13 MARKET FOR CONTAMINATION TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 DISEASE TESTING 
           6.3.1 GROWING DISEASE INCIDENCE AND RISING PATIENT AWARENESS TO DRIVE MARKET
                    TABLE 14 MARKET FOR DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 DRUG DISCOVERY & DEVELOPMENT 
           6.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS TO DRIVE MARKET
                    TABLE 15 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 ATP ASSAYS MARKET, BY PRODUCT (Page No. - 89)
    7.1 INTRODUCTION 
          TABLE 16 ATP ASSAYS INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    7.2 CONSUMABLES & ACCESSORIES 
          TABLE 17 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE
          TABLE 18 MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 19 MARKET FOR CONSUMABLES & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.1 REAGENTS & KITS
                    7.2.1.1 Growing prevalence of infectious diseases and increasing use of contamination testing to drive segment
                                TABLE 20 REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.2 MICROPLATES
                    7.2.2.1 Increasing demand in drug discovery and preclinical safety studies to drive segment
                                TABLE 21 MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.3 OTHER CONSUMABLES & ACCESSORIES
                    TABLE 22 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 INSTRUMENTS 
          TABLE 23 MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 24 MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 25 KEY ATP INSTRUMENTS AVAILABLE
           7.3.1 LUMINOMETERS
                    7.3.1.1 Low cost, quick output, and ease of usage to drive segment
                                TABLE 26 LUMINOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           7.3.2 SPECTROPHOTOMETERS
                    7.3.2.1 Higher cost of spectrophotometers to limit market
                                TABLE 27 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 ATP ASSAYS MARKET, BY END USER (Page No. - 101)
    8.1 INTRODUCTION 
          TABLE 28 ATP ASSAYS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE ATP ASSAYS END USER MARKET DURING STUDY PERIOD
                    TABLE 29 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 FOOD & BEVERAGE INDUSTRY 
           8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION AND GROWING NEED FOR FOOD SAFETY TO DRIVE MARKET
                    TABLE 30 MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 
           8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET
                    TABLE 31 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 ACADEMIC & RESEARCH INSTITUTES 
           8.5.1 INCREASING USE IN CELL CULTURE EXPERIMENTS AND CANCER RESEARCH TO DRIVE MARKET
                    TABLE 32 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 ATP ASSAYS MARKET, BY REGION (Page No. - 109)
    9.1 INTRODUCTION 
          TABLE 33 ATP ASSAYS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 34 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT
                    TABLE 34 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 35 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 36 NORTH AMERICA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 37 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 38 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 39 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.2 US
                    9.2.2.1 US to dominate North American market during forecast period
                                TABLE 40 US: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 41 US: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 42 US: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 43 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 44 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Government funding programs for life science research to drive market
                                TABLE 45 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 46 CANADA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 47 CANADA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 48 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 49 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 50 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 51 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 52 EUROPE: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 54 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 55 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers to drive market
                                TABLE 56 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 57 GERMANY: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 58 GERMANY: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 59 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 60 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Increasing R&D expenditure in pharmaceutical companies and growing life science industry to drive market
                                FIGURE 35 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
                                TABLE 61 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 62 UK: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 63 UK: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 64 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 65 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 FRANCE
                    9.3.4.1 Highly profi                                TABLE agro-food sector and increased focus on biotechnology R&D to drive market
                                TABLE 66 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 67 FRANCE: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 68 FRANCE: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 69 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 70 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Presence of well-developed healthcare system and high cancer burden to drive market
                                TABLE 71 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 72 ITALY: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 73 ITALY: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 74 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 75 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Growth in personalized medicines and clinical diagnostics to drive market
                                TABLE 76 SPAIN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 77 SPAIN: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 78 SPAIN: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 79 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 80 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 81 REST OF EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 82 REST OF EUROPE: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 83 REST OF EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 84 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 85 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 36 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT
                    TABLE 86 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 88 ASIA PACIFIC: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 90 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Increasing pharmaceutical R&D investments to drive market
                                TABLE 92 CHINA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 93 CHINA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 94 CHINA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 95 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 96 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 JAPAN
                    9.4.3.1 Higher incidence of cancer and greater geriatric population to drive market
                                TABLE 97 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 98 JAPAN: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 99 JAPAN: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 100 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 101 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Growing adoption of ATP assay techniques in research and clinical applications to drive market
                                TABLE 102 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 103 INDIA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 INDIA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 105 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 106 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 107 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 108 REST OF ASIA PACIFIC: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 109 REST OF ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 110 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 111 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 112 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 113 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 114 LATIN AMERICA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 115 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 116 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 117 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.2 BRAZIL
                    9.5.2.1 Increasing research activities and growing pharmaceutical industry to drive market
                                TABLE 118 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 119 BRAZIL: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 120 BRAZIL: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 121 BRAZIL: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 122 BRAZIL: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.3 MEXICO
                    9.5.3.1 Increase in research centers and manufacturing units to drive market
                                TABLE 123 MEXICO: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 124 MEXICO: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 125 MEXICO: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 126 MEXICO: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 127 MEXICO: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 128 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 129 REST OF LATIN AMERICA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 130 REST OF LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 131 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 132 REST OF LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 GROWING FUNDING INITIATIVES AND INCREASING STRATEGIC PARTNERSHIPS TO DRIVE MARKET
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 133 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 134 MIDDLE EAST & AFRICA: MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 135 MIDDLE EAST & AFRICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 136 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 137 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 166)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY MAJOR PLAYERS 
             TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ATP ASSAYS MARKET
     10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 
             FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN ATP ASSAYS INDUSTRY
     10.4 MARKET RANKING OF KEY PLAYERS IN ATP ASSAYS INDUSTRY
             FIGURE 38 MARKET RANKING, BY KEY PLAYER, 2022
     10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 39 MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
     10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 DYNAMIC COMPANIES
             10.6.3 STARTING BLOCKS
             10.6.4 RESPONSIVE COMPANIES
                       FIGURE 40 ATP ASSAYS INDUSTRY: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
     10.7 COMPANY FOOTPRINT 
            TABLE 139 COMPANY FOOTPRINT: MARKET (2022)
             10.7.1 PRODUCT FOOTPRINT
                        TABLE 140 PRODUCT FOOTPRINT: MARKET (2022)
             10.7.2 APPLICATION FOOTPRINT
                        TABLE 141 APPLICATION FOOTPRINT: MARKET (2022)
             10.7.3 END USER FOOTPRINT
                        TABLE 142 END USER FOOTPRINT: MARKET (2022)
             10.7.4 GEOGRAPHICAL FOOTPRINT
                        TABLE 143 REGIONAL FOOTPRINT: MARKET (2022)
     10.8 COMPETITIVE SCENARIOS AND TRENDS 
             10.8.1 KEY PRODUCT LAUNCHES
                        TABLE 144 KEY PRODUCT LAUNCHES, JANUARY 2019–JUNE 2023
             10.8.2 KEY DEALS
                        TABLE 145 KEY DEALS, JANUARY 2019–JUNE 2023
             10.8.3 OTHER KEY DEVELOPMENTS
                        TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2019–JUNE 2023
 
11 COMPANY PROFILES (Page No. - 182)
     11.1 KEY PLAYERS 
(Business overview, Products offered, Recent Developments, MNM view)*
             11.1.1 THERMO FISHER SCIENTIFIC INC.
                        TABLE 147 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                        FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
             11.1.2 MERCK KGAA
                        TABLE 148 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022)
             11.1.3 PROMEGA CORPORATION
                        TABLE 149 PROMEGA CORPORATION: COMPANY OVERVIEW
             11.1.4 NEOGEN CORPORATION
                        TABLE 150 NEOGEN CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.5 PERKINELMER INC.
                        TABLE 151 PERKINELMER INC.: COMPANY OVERVIEW
                        FIGURE 44 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
             11.1.6 AGILENT TECHNOLOGIES, INC.
                        TABLE 152 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
                        FIGURE 45 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             11.1.7 PROMOCELL GMBH
                        TABLE 153 PROMOCELL GMBH: COMPANY OVERVIEW
             11.1.8 DANAHER CORPORATION
                        TABLE 154 DANAHER CORPORATION: COMPANY OVERVIEW
                        FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.9 LONZA
                        TABLE 155 LONZA: COMPANY OVERVIEW
                        FIGURE 47 LONZA: COMPANY SNAPSHOT (2022)
             11.1.10 ABCAM PLC
                        TABLE 156 ABCAM PLC: COMPANY OVERVIEW
                        FIGURE 48 ABCAM PLC: COMPANY SNAPSHOT (2022)
             11.1.11 3M
                        TABLE 157 3M: COMPANY OVERVIEW
                        FIGURE 49 3M: COMPANY SNAPSHOT (2022)
             11.1.12 ABNOVA CORPORATION
                        TABLE 158 ABNOVA CORPORATION: COMPANY OVERVIEW
             11.1.13 GENO TECHNOLOGY INC.
                        TABLE 159 GENO TECHNOLOGY INC.: COMPANY OVERVIEW
             11.1.14 AAT BIOQUEST, INC.
                        TABLE 160 AAT BIOQUEST, INC.: COMPANY OVERVIEW
             11.1.15 BIOTHEMA AB
                        TABLE 161 BIOTHEMA AB: COMPANY OVERVIEW
             11.1.16 BIOTIUM
                        TABLE 162 BIOTIUM: COMPANY OVERVIEW
             11.1.17 CREATIVE BIOARRAY
                        TABLE 163 CREATIVE BIOARRAY: COMPANY OVERVIEW
             11.1.18 CANVAX
                        TABLE 164 CANVAX: COMPANY OVERVIEW
             11.1.19 ELABSCIENCE BIOTECHNOLOGY INC.
                        TABLE 165 ELABSCIENCE BIOTECHNOLOGY INC.: COMPANY OVERVIEW
             11.1.20 MBL INTERNATIONAL CORPORATION
                        TABLE 166 MBL INTERNATIONAL CORPORATION: COMPANY OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 RUHOF CORPORATION
             11.2.2 CHARM SCIENCES
             11.2.3 BIO SHIELD TECH, LLC
             11.2.4 CAYMAN CHEMICAL
             11.2.5 CELL SIGNALING TECHNOLOGY, INC.
 
12 APPENDIX (Page No. - 234)
     12.1 INSIGHTS FROM INDUSTRY EXPERTS 
     12.2 DISCUSSION GUIDE 
     12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.4 CUSTOMIZATION OPTIONS 
     12.5 RELATED REPORTS 
     12.6 AUTHOR DETAILS 

 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ATP assays market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side and demand side are detailed below. Industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the ATP assays industry were interviewed to obtain and verify both the qualitative and quantitative aspects of this research study. A robust primary research methodology has been adopted to validate the contents of the report and fill in the gaps.

A breakdown of the primary respondents is provided below:

ATP Assays Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2022: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

PerkinElmer, Inc.

Assistant Manager Sales

Thermo Fisher Scientific,Inc.

Assistant Project Manager

BioThema AB

Business Development Manager

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis) primary interviews, and top-down approach (assessment of Individual shares of each ATP assay product, application, and end-user segment).

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Market Definition

ATP assays are procedures that can measure cell viability based on the detection of ATP using detection methods such as colorimetric, fluorescent, and bioluminescence. These assays are used to measure the presence of microorganisms through the detection of adenosine triphosphate (ATP). These assays are used for live cell quantification, contamination testing, and disease testing based on the amount of ATP present in different samples such as blood, urine, animal tissue, and food & beverage samples.

Key Stakeholders

  • Senior Management
  • Finance/Purchase Department
  • Operations Department
  • R&D Department

Objectives of the Study

  • To define, describe, segment, and forecast the ATP assays market by product, application, end user, and region
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall ATP assays market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To estimate and forecast the size of the ATP assays market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the ATP assays market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships, of the leading players in the ATP assays market
  • To benchmark players within the ATP assays market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

  • Further breakdown of the Rest of Europe ATP assays market into Switzerland, the Netherlands, Belgium, and others.
  • Further breakdown of the Middle East & Africa ATP assays market into Saudi Arabia, the UAE, and others.

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
AST 7417
Published ON
Jun, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the ATP Assays Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback